Inovio Pharma (INO) Stock Price, Quote & News

Company Profile

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-...

Industry: Biotechnology

Sector: Healthcare

Phone: 267 440 4200

Website: www.inovio.com

Address:

660 West Germantown Pike, Suite 110, Plymouth Meeting, United States

updownsides May. 13 at 6:58 AM

$INO Earnings is going to be great!!

1 · Reply

TangibleOne May. 13 at 2:54 AM

$INO this and SKM (ticker) for Anthropic pre IPO proxy!!!!

1 · Reply

Lookingdown May. 13 at 2:26 AM

$INO Passing it along for anyone who wants to read it and yes Inovio INO-9012 and the Cellectra was referenced in this scientific article 😉 Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial May 12, 2026 https://www.nature.com/articles/s43018-026-01163-w

3 · Reply

Lookingdown May. 12 at 10:44 PM

$INO How's it going my Bullish Friends 😉😎💪💎🫶

8 · Reply

ScatP392 May. 12 at 10:23 PM

$INO someone is accumulating AH

1 · Reply

Zskylar May. 12 at 9:52 PM

$INO flat day

1 · Reply

CultOfTardsINO May. 12 at 8:52 PM

$INO wait until they tell you 3107 is dead tomorrow my man

2 · Reply

tau72 May. 12 at 8:39 PM

$INO Pre Trial filed on yesterday 5/11/2026 Select 506 E 5/11/2026 Pre Trial Memorandum/Statement BY VGXI, INC. AND GENEONE LIFE SCIENCE, INC. No 15397903 Select 507 E 5/11/2026 Affidavit/Certificate of Service of VGXI, INC. AND GENEONE LIFE SCIENCE, INC. PRETRIAL STATEMENT ON 05/11/2026 TO INOVIO PHARMACEUTICALS, INC. No 15397938 Select 508 E 5/11/2026 Pre Trial Memorandum/Statement BY VGXI, INC. AND GENEONE LIFE SCIENCE, INC. Yes 15397975 Select 509 E 5/11/2026 Pre Trial Memorandum/Statement BY INOVIO PHARMACEUTICALS, INC No 15398814 Select 510 E 5/11/2026 Affidavit/Certificate of Service of INOVIO PHARMACEUTICALS, INC.'S PRE-TRIAL STATEMENT ON 05/11/2026 TO ALL PARTIES

2 · Reply

Bli1 May. 12 at 8:15 PM

$INO nasty close

3 · Reply

patcarr May. 12 at 7:35 PM

$INO A couple of more hantavirus cases today, and with an incubation period of 42 days things could still get interesting.

1 · Reply

Options Volatility and Implied Earnings Moves Today, May 13, 2026

BABA CSCO EOSE MVIS PSFE TM WIX

May 11, 2026, 7:53 AM EDT - 2 days ago

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS MRNA NVAX

May 8, 2026, 8:05 AM EDT - 5 days ago

INOVIO to Participate in Upcoming Scientific Conferences

May 1, 2026, 4:05 PM EDT - 11 days ago

INOVIO to Report First Quarter Financial Results on May 13, 2026

Apr 2, 2026, 8:55 AM EDT - 5 weeks ago

INOVIO Announces Pricing of $17.5 Million Public Offering

Apr 1, 2026, 8:05 PM EDT - 5 weeks ago

INOVIO Announces Proposed Public Offering

Apr 1, 2026, 10:29 AM EDT - 5 weeks ago

INOVIO to Participate in Upcoming Scientific Conference

2026-03-23T12:41:57.000Z - 7 weeks ago

Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims

Mar 12, 2026, 4:30 PM EDT - 2 months ago

Inovio Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 12, 2026, 4:05 PM EDT - 2 months ago

INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

2026-03-12T12:05:23.000Z - 2 months ago

Options Volatility and Implied Earnings Moves Today, March 12, 2026

ADBE BLDP DG LEN S SNDL ULTA

Mar 10, 2026, 1:40 PM EDT - 2 months ago

Inovio Pharmaceuticals Transcript: The Citizens Life Sciences Conference 2026

Mar 5, 2026, 4:05 PM EST - 2 months ago

INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

Mar 4, 2026, 8:52 AM EST - 2 months ago

Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

2026-03-04T13:15:14.000Z - 2 months ago

Inovio, Akeso announce clinical collaboration

Mar 4, 2026, 8:05 AM EST - 2 months ago

INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

Feb 25, 2026, 12:40 PM EST - 2 months ago

Inovio Pharmaceuticals Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 12, 2026, 8:05 AM EST - 3 months ago

INOVIO to Participate in Upcoming Scientific and Investor Conferences

2025-12-29T13:10:42.000Z - 4 months ago

Inovio announces U.S. FDA accepted BLA for INO-3107

Dec 29, 2025, 8:05 AM EST - 4 months ago

FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Dec 19, 2025, 4:05 PM EST - 5 months ago

INOVIO Reports Inducement Grant Under Inducement Plan

Dec 2, 2025, 8:30 AM EST - 5 months ago

Inovio Pharmaceuticals Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 8:05 AM EST - 6 months ago

INOVIO to Participate in December Investor Conferences

2025-11-14T11:45:36.000Z - 6 months ago

Inovio price target raised to $6 from $5 at Piper Sandler

2025-11-11T13:45:25.000Z - 6 months ago

Inovio 13.16M share Spot Secondary priced at $1.90

Nov 11, 2025, 8:40 AM EST - 6 months ago

INOVIO Announces Pricing of $25 Million Public Offering

2025-11-10T23:20:12.000Z - 6 months ago

Inovio announces common stock offering, no amount given

Nov 10, 2025, 4:30 PM EST - 6 months ago

Inovio Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:05 PM EST - 6 months ago

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

2025-11-10T12:05:03.000Z - 6 months ago

Options Volatility and Implied Earnings Moves Today, November 10, 2025

ASTS BBAI GEVO OXY PLUG RGTI WULF

2025-11-03T13:10:55.000Z - 6 months ago

Inovio completes rolling submission of BLA for INO-3107

Nov 3, 2025, 8:05 AM EST - 6 months ago

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Oct 27, 2025, 8:05 AM EDT - 7 months ago

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 23, 2025, 4:05 PM EDT - 7 months ago

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

Oct 21, 2025, 8:05 AM EDT - 7 months ago

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Sep 5, 2025, 7:00 AM EDT - 8 months ago

Inovio Pharmaceuticals Transcript: H.C. Wainwright 27th Annual Global Investment Conference

2025-08-26T12:11:08.000Z - 9 months ago

Inovio to begin rolling submission of BLA for INO-3107

Aug 26, 2025, 8:05 AM EDT - 9 months ago

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

Aug 25, 2025, 8:05 AM EDT - 9 months ago

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 12, 2025, 4:30 PM EDT - 9 months ago

Inovio Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:05 PM EDT - 9 months ago

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

2025-08-12T11:05:14.000Z - 9 months ago

Options Volatility and Implied Earnings Moves Today, August 12, 2025

ALT CAVA CRWV HYLN PSFE RGTI SE

2025-08-11T12:10:39.000Z - 9 months ago

Inovio announces peer-reviewed data from INO-3107 study

Aug 11, 2025, 8:05 AM EDT - 9 months ago

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Aug 4, 2025, 4:05 PM EDT - 10 months ago

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 7, 2025, 4:05 PM EDT - 11 months ago

INOVIO to Present at Upcoming Scientific Conference

Jul 1, 2025, 7:00 AM EDT - 11 months ago

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

May 13, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings Call Transcript: Q1 2025

May 13, 2025, 4:05 PM EDT - 1 year ago

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 8, 2025, 11:30 AM EDT - 1 year ago

Inovio Pharmaceuticals Transcript: The Citizens JMP Life Sciences Conference 2025

Apr 30, 2025, 8:05 AM EDT - 1 year ago

INOVIO to Present at Upcoming Scientific and Investor Conferences

Apr 29, 2025, 8:05 AM EDT - 1 year ago

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 9, 2025, 8:05 AM EDT - 1 year ago

INOVIO to Present at Upcoming Scientific Conferences

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings Call Transcript: Q4 2024

Mar 18, 2025, 4:05 PM EDT - 1 year ago

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 13, 2025, 6:15 PM EDT - 1 year ago

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

Mar 12, 2025, 12:55 PM EDT - 1 year ago

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

Feb 12, 2025, 3:20 PM EST - 1 year ago

Inovio Pharmaceuticals Transcript: Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025, 8:00 AM EST - 1 year ago

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications

Feb 10, 2025, 8:05 AM EST - 1 year ago

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference

Jan 29, 2025, 4:14 PM EST - 1 year ago

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

updownsides May. 13 at 6:58 AM

$INO Earnings is going to be great!!

1 · Reply

TangibleOne May. 13 at 2:54 AM

$INO this and SKM (ticker) for Anthropic pre IPO proxy!!!!

1 · Reply

Lookingdown May. 13 at 2:26 AM

3 · Reply

Lookingdown May. 12 at 10:44 PM

$INO How's it going my Bullish Friends 😉😎💪💎🫶

8 · Reply

ScatP392 May. 12 at 10:23 PM

$INO someone is accumulating AH

1 · Reply

Zskylar May. 12 at 9:52 PM

$INO flat day

1 · Reply

CultOfTardsINO May. 12 at 8:52 PM

$INO wait until they tell you 3107 is dead tomorrow my man

2 · Reply

tau72 May. 12 at 8:39 PM

2 · Reply

Bli1 May. 12 at 8:15 PM

$INO nasty close

3 · Reply

patcarr May. 12 at 7:35 PM

$INO A couple of more hantavirus cases today, and with an incubation period of 42 days things could still get interesting.

1 · Reply

Iluvfor30s May. 12 at 6:59 PM

$INO INOVIO PHARMACEUTICALS, INC.'S PRE-TRIAL STATEMENT ON 05/11/2026 TO ALL PARTIES "We are not expecting to have a product in the next 35 years, so let's continue into this trial with the sole purpose of sodomizing our retail investors."

0 · Reply

GermanBulle May. 12 at 6:57 PM

$INO this makari guy is out as FDA Commissioner. That caused the pump imo. So let’s see what it brings 4 little INO. Maybe Hantavirus is over maybe not. ER 2morrow will puh that or will drop it. Bright sky’s ahead. Open the door, girl on top! We are waiting

0 · Reply

Bli1 May. 12 at 6:43 PM

$INO this feels like buying moderna or biontech in early 2020

6 · Reply

phoenixgamer May. 12 at 6:39 PM

$INO Hantavirus pump. Notice how they didn't let it drop below 1.00. They want to hold us here for a bit longer. That final plunge below 1.00 is coming and is the signal that the skyrocket news we have all been waiting for is finally about to materialize. Long and strong, baby.✌️

0 · Reply

Bli1 May. 12 at 5:58 PM

$INO accumulation at its best. The breakout we had was a powerfull indicator of what is possible here.

0 · Reply

Bli1 May. 12 at 5:42 PM

$INO dna tech ready to use for pandemic outbreaks.

2 · Reply

idan_vaknin May. 12 at 5:35 PM

$INO 100$ pandemic soon 🏦💵

1 · Reply

Mvc9111 May. 12 at 5:26 PM

$INO here we go again

1 · Reply

dogbone98 May. 12 at 4:31 PM

$INO The notion that anyone would have to get paid to state the truth about this stock- down 98.3% over past 5 years, poor management, no FDA approvals since founding, etc., is absurd. A pumper, OTOH, yeah. It will be interesting to hear Shea spin the 3107 situation tomorrow. Since they didn't get accelerated approval, a withdrawal of the BLA isn't out of the question, as that would be better than a CRL.

1 · Reply

BentleyT99 May. 12 at 3:10 PM

$INO

2 · Reply

rioe May. 12 at 3:06 PM

$INO Keep out the noise and focus on your individual goals. Bashers/losers mostly paid to post garbage all day to distract us. We know what we invested in, we don’t need to be told what we need to do. We invested based on the DD we made and I for one will continue to add. Our Journey to $100 will not be stopped! 🚀🚀

0 · Reply

CultOfTardsINO May. 12 at 2:33 PM

$INO so you guys got rich now right?

0 · Reply

Market Cap	99.30M
Revenue (ttm)	70,000.00
Net Income (ttm)	-84.95M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-121,357.14%
Debt to Equity Ratio	0.00

Volume	2,992,500
Avg Vol	2,568,052
Day's Range	N/A - N/A
Shares Out	69.44M
Stochastic %K	45%
Beta	1.43
Analysts	Sell
Price Target	$5.96